Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Metastatic bone and soft tissue sarcomas often relapse after chemotherapy (CHT) and molecular targeted therapy (mTT), maintaining a severe prognosis. A subset of sarcoma cancer stem cells (sCSC) is hypothesized to resist conventional drugs and sustain disease relapses. We investigated the immunother...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Mesiano, Giulia, Grignani, Giovanni, Fiorino, Erika, Leuci, Valeria, Rotolo, Ramona, D’Ambrosio, Lorenzo, Salfi, Chiara, Gammaitoni, Loretta, Giraudo, Lidia, Pisacane, Alberto, Butera, Sara, Pignochino, Ymera, Basiricó, Marco, Capozzi, Federica, Sapino, Anna, Aglietta, Massimo, Sangiolo, Dario
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208452/
https://ncbi.nlm.nih.gov/pubmed/30393581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2018.1465161
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados